London, February 8, 2026 — A seemingly straightforward case of menopause symptoms masked a potentially life-threatening condition for a 55-year-old woman, highlighting the importance of persistent investigation and the emerging role of new medications in reversing liver damage.
Hidden Liver Damage: When Menopause Masked a Serious Illness
Belinda Whitlock’s experience underscores how easily serious conditions can be misattributed, and how weight-loss drugs are offering new hope for those with fatty liver disease.
- Fatty liver disease, affecting up to one in five adults, often presents with no early symptoms.
- Misdiagnosis is common, with symptoms frequently attributed to other conditions like menopause.
- New GLP-1 drugs, like Mounjaro, are showing promise in reversing liver damage, even in advanced cases.
- Early detection and lifestyle changes are crucial for managing and potentially reversing the condition.
What is fatty liver disease, and why is it often undiagnosed? Fatty liver disease is a condition where excess fat builds up in the liver, causing inflammation and potentially leading to scarring. It’s often symptomless in its early stages, leading to an estimated 80 percent of those affected being unaware they have it.
Belinda Whitlock repeatedly visited her general practitioner complaining of fatigue, nausea, and unexplained stomach pain. The initial diagnosis? Menopause. As the symptoms worsened, forcing her to cancel social engagements and head straight to bed after work, she was prescribed hormone replacement therapy (HRT). But her health didn’t improve.
A twist of fate intervened. The HRT caused vaginal bleeding, prompting an ultrasound referral. During the scan, the sonographer unexpectedly examined her abdomen instead of performing a transvaginal scan—and spotted signs of a fatty liver. Further testing revealed advanced liver fibrosis, where scarring impedes the liver’s function.
“It hit me like a sledgehammer,” recalls Whitlock, a mother of four. “My mum died of liver cancer when she was just 46, and I left the doctors with no real information about what this meant for me. All I could think of was my children – I thought I was going to die just like my mum did.”
Whitlock dramatically altered her lifestyle, adopting a Mediterranean diet, drinking coffee daily, and eliminating takeaways. After seven months, she lost two stone, but scans showed minimal improvement in her liver health. Determined to find a solution, she turned to a different approach.
At the time, Whitlock had a body mass index (BMI) of 45, classifying her as severely obese. With no drugs licensed in the UK specifically for liver disease, she began a private prescription for a GLP-1 weight-loss drug—Mounjaro—in August, after reading about its potential impact on the condition.
Since then, she’s lost an additional five stone, bringing her BMI down to 31, and recent scans have shown remarkable reversal of her liver fibrosis. “I feel like the end is now in sight and I just need to keep doing what I’m doing,” she says.
Belinda Whitlock says she feared she would die from liver disease as her mum had done at just 46
Experts believe GLP-1 drugs could be a game-changer in tackling liver disease. “The rise in liver disease is alarming,” says Professor Philip Newsome, a liver expert at King’s College London. “That’s why the use of weight-loss drugs to treat the condition is really promising. We now have compelling research evidence that they can help reverse liver damage – something we didn’t previously think was possible.”
The surge in cases is largely attributed to poor diets and sedentary lifestyles. The condition progresses through four stages, starting with fat accumulation, leading to inflammation and ultimately, scarring. If left untreated, it can progress to cirrhosis, an end-stage liver disease requiring a transplant for survival.
Experts say GLP-1 drugs such as Mounjaro could prove key to tackling liver disease
“The old view was that scarring couldn’t be reversed – and certainly not cirrhosis,” says Professor Newsome. “But we now know that if you treat the underlying cause of liver damage, you can see remarkable remodelling of scar tissue. You might not return the liver to normal, but you can move it back to a much less harmful state.”
Gillian Scott, a 57-year-old civil servant, experienced a similar transformation. Diagnosed with cirrhosis in 2023 after years of poorly controlled type 2 diabetes and obesity, she began Mounjaro in June 2024. She has since lost nine stone, and scans indicate her condition has improved from cirrhosis to fibrosis.
“I’m really hopeful now,” says Scott. “When I was diagnosed, I thought I was going to die. But I’ve shown it’s never too late with the right treatment.”
Research supports the use of weight-loss drugs for liver disease. A 2024 study in the New England Journal Of Medicine found that 62 percent of patients taking the highest maintenance dose of Mounjaro (15mg) experienced complete resolution of their fatty liver disease, with liver function returning to normal.
“We believe these drugs have benefits beyond weight loss and blood-sugar control,” says Professor Newsome. “We don’t yet fully understand why, but there is evidence that the GLP-1 component may have a direct effect on immune cells in the liver.”
Belinda’s weight loss, through the help of Mounjaro, has helped to begin reversing her liver fibrosis
While GLP-1 drugs are approved in the US and Europe for this condition, they are not yet available on the National Health Service (NHS) in the UK. A decision is expected this summer.
For Whitlock, the delay is costly. She continues to pay hundreds of pounds monthly for a medication she believes is saving her life. “I’ve dipped into my work pension to afford it, and after the latest price rise I’ve had to ask my daughter for help,” she says. “The NHS really needs to catch up with the benefits these drugs can offer.”
The British Liver Trust estimates that 80 per cent of those with fatty liver disease are undiagnosed as there are often no symptoms in the early stages
What are your thoughts on the potential of GLP-1 drugs to treat liver disease? Share your comments below.
